Published in Ann Neurol on May 01, 1993
Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry (2003) 3.87
Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol (2011) 3.56
Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med (2011) 2.60
Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? Nat Rev Neurosci (2010) 2.34
Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med (2009) 1.95
Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol (2010) 1.80
Alzheimer's disease after remote head injury: an incidence study. J Neurol Neurosurg Psychiatry (1997) 1.53
Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol (1995) 1.53
Long term neuropsychological outcome after head injury: relation to APOE genotype. J Neurol Neurosurg Psychiatry (2003) 1.41
Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol (2002) 1.38
Effect of smoking and time on cognitive function in the elderly without dementia. Neurology (2005) 1.19
The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol (2013) 1.18
Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol (2015) 1.12
Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry (1996) 1.12
Gene-environment interactions in mental disorders. World Psychiatry (2004) 1.12
Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel. Alzheimers Res Ther (2014) 1.11
Impact of age on long-term recovery from traumatic brain injury. Arch Phys Med Rehabil (2008) 1.05
Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. Mol Pathol (2003) 1.02
Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies. Front Neurol (2013) 1.00
Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement. Neurology (2006) 0.98
Quantitative imaging methods for the development and validation of brain biomechanics models. Annu Rev Biomed Eng (2012) 0.96
Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cell Mol Neurobiol (1999) 0.96
Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J Neurochem (2000) 0.95
Lifetime Prevalence and Factors Associated with Head Injury among Older People in Low and Middle Income Countries: A 10/66 Study. PLoS One (2015) 0.93
Multiple etiologies for Alzheimer disease are revealed by segregation analysis. Am J Hum Genet (1994) 0.91
Mechanisms and potential therapeutic applications of microglial activation after brain injury. CNS Neurosci Ther (2014) 0.89
Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (2014) 0.87
Implementation of Neuropsychological Testing Models for the High School, Collegiate, and Professional Sport Settings. J Athl Train (2001) 0.87
Concussion in Chronic Traumatic Encephalopathy. Curr Pain Headache Rep (2015) 0.83
A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids. J Neurotrauma (2014) 0.83
Improved measurement of brain deformation during mild head acceleration using a novel tagged MRI sequence. J Biomech (2014) 0.82
Neurochemical profile of dementia pugilistica. J Neurotrauma (2013) 0.82
Traumatic brain injury: future assessment tools and treatment prospects. Neuropsychiatr Dis Treat (2008) 0.82
Dementia / Alzheimer's Disease. BMC Womens Health (2004) 0.81
Chronic traumatic encephalopathy: the dangers of getting "dinged". Springerplus (2012) 0.80
APP as a Protective Factor in Acute Neuronal Insults. Front Mol Neurosci (2017) 0.75
Head Injury as a Risk Factor for Dementia and Alzheimer's Disease: A Systematic Review and Meta-Analysis of 32 Observational Studies. PLoS One (2017) 0.75
Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary Report. Alzheimers Dement (N Y) (2017) 0.75
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
Influence of education and occupation on the incidence of Alzheimer's disease. JAMA (1994) 8.43
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
Influence of leisure activity on the incidence of Alzheimer's disease. Neurology (2001) 4.49
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology (2010) 4.06
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol (2001) 3.43
Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med (1998) 3.23
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology (1999) 3.12
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol (1995) 3.00
Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry (1996) 2.99
Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol (1998) 2.96
Depression, intellectual impairment, and Parkinson disease. Neurology (1981) 2.96
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry (1999) 2.92
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology (2004) 2.59
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol (1993) 2.48
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology (2003) 2.44
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry (1994) 2.40
The Comprehensive assessment and Referral Evaluation (CARE)--rationale, development and reliability. Int J Aging Hum Dev (1977) 2.35
Education and rates of cognitive decline in incident Alzheimer's disease. J Neurol Neurosurg Psychiatry (2006) 2.29
Cognitive test performance among nondemented elderly African Americans and whites. Neurology (1998) 2.28
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet (1994) 2.24
Premorbid weight, body mass, and varsity athletics in ALS. Neurology (2002) 2.23
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15
Smoking and Parkinson's disease in twins. Neurology (2002) 2.15
The influence of smoking on the risk of Alzheimer's disease. Neurology (1999) 2.14
Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol (1999) 2.13
The association of incident dementia with mortality in PD. Neurology (2002) 2.07
How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord (1998) 2.03
Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol (1999) 1.96
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology (2008) 1.91
Effect of literacy on neuropsychological test performance in nondemented, education-matched elders. J Int Neuropsychol Soc (1999) 1.91
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol (2011) 1.90
The SHORT-CARE: an efficient instrument for the assessment of depression, dementia and disability. J Gerontol (1984) 1.87
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry (1998) 1.85
Is "subcortical dementia" a recognizable clinical entity? Ann Neurol (1983) 1.85
Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol (1995) 1.85
Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology (1995) 1.84
A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA (2001) 1.82
Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology (1985) 1.81
Weight loss in early stage of Huntington's disease. Neurology (2002) 1.79
Normative data for a brief neuropsychological battery administered to English- and Spanish-speaking community-dwelling elders. J Int Neuropsychol Soc (1998) 1.79
Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology (1992) 1.78
Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol (1997) 1.78
Quality of life in patients with Alzheimer's disease as reported by patient proxies. J Am Geriatr Soc (1996) 1.78
The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology (2002) 1.77
Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry (1999) 1.77
Antecedent clinical features associated with dementia in Parkinson's disease. Neurology (1993) 1.74
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology (2006) 1.73